[Treatment outcome of advanced Hodgkin's disease based on using an alternating program ChLVPP (chlorambucil, vinblastine, procarbazine, prednisone) and ABV (doxorubicin, bleomycin, vinblastine)].
作者信息
Komarnicki M, Balcerzak A, Górski P, Pawlak L, Hansz J
机构信息
Klinika Hematologii Instytutu Chorób Wewnetrznych Akademii Medycznej im. K. Marcinkowskiego, Poznaniu.
出版信息
Acta Haematol Pol. 1994;25(4):363-8.
PMID:7531381
Abstract
Twenty nine patients (7 women, 22 men) with III and IV stage of Hodgkin's disease were treated according to alternating programme ChLVPP/ABV. The results were evaluated in 27 patients. Complete remission was obtained in 41% (11 patients), partial remission in 22% (6 patients). Applied treatment revealed a relatively small toxicity.
摘要
Zotero 插件